Continuous subcutaneous insulin infusion in young girls: a two-year follow-up study
2007 (English)In: European Diabetes Nursing, ISSN 1551-7853, E-ISSN 1551-7861, Vol. 4, no 1, 34-39 p.Article in journal (Refereed) Published
To investigate why young girls decided to start continuous subcutaneousinsulin infusion (CSII) therapy, and to examine their opinions and concerns withregard to using an insulin pump. In addition, the girls were evaluated for HbA1cvalues, insulin requirements and body mass index standard deviation score (BMISDS) over a period of two years after starting CSII compared with a group of girlsusing multiple daily injections (MDI).
Twelve girls (mean age 10.8 years) starting CSII were followed over a period of two years. Why the girls started CSII and whether they preferred CSII orMDI were investigated. Their statements about CSII were analysed and categorisedby two paediatric diabetes nurses. On four occasions HbA1c values, insulin require-ment and BMI SDS were collected and compared with those of a control group of 12 girls using MDI for the same period of time.
The girls started CSII due to a desire to test pump therapy, and their experiences of unstable blood glucose. They preferred CSII to MDI. The main positive statements were categorised as ‘quality-of-life benefits’. The main negativecategory was ‘the pump gets in the way’. In the CSII group, HbA1c decreased from8.5 (7.4–9.5) to 7.5 (6.9–8.1) (p<0.05) over two years, and the insulin requirementdecreased by 30%. In the control group these values were unchanged. There wereno changes in the BMI SDS mean values for either group.
CSII was well accepted by the young girls, facilitated a decrease inHbA1c values, and did not result in weight gain.
Place, publisher, year, edition, pages
John Wiley & Sons, 2007. Vol. 4, no 1, 34-39 p.
CSII, children, adolescents, females, type 1 diabetes
Research subject Caring Sciences
IdentifiersURN: urn:nbn:se:uu:diva-224271DOI: 10.1002/edn.74OAI: oai:DiVA.org:uu-224271DiVA: diva2:716180